Concepedia

Zhisong He

ZH

Statistics

Publications

12

Citations

486

H-Index

12

Active since

2010

Affiliations

Peking University First Hospital(Current)

Peking University

Peking University Cancer Hospital

Sun Yat-sen University Cancer Center

Sun Yat-sen University

Zhisong He is an author at Peking University First Hospital specializing in oncology, medicine, and metastasis.

Publications per year

2010–2024

12

Publications

12

Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials

Xinan Sheng, Lin Wang, Zhisong He et al. · Journal of Clinical Oncology · 2023 · 156 citations · Full text

, , +17

Single-cell transcriptomics reveals a low CD8<sup>+</sup> T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma

Yulu Peng, Longbin Xiong, Zhaohui Zhou et al. · Journal for ImmunoTherapy of Cancer · 2022 · 70 citations · Full text

, , +17

A phase II study of RC48-ADC in HER2-positive patients with locally advanced or metastatic urothelial carcinoma.

Xinan Sheng, Ai-Ping Zhou, Xin Yao et al. · Journal of Clinical Oncology · 2019 · 39 citations

, , +17

Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with<sup>68</sup>Ga-N188

Jianhua Zhang, Xiaojiang Duan, Xueqi Chen et al. · Journal of Nuclear Medicine · 2024 · 34 citations · Full text

, , +17

RC48-ADC for metastatic urothelial carcinoma with HER2-positive: Combined analysis of RC48-C005 and RC48-C009 trials.

Xinan Sheng, Zhisong He, Yanxia Shi et al. · Journal of Clinical Oncology · 2022 · 33 citations

, , +16

1–5 of 12